Research Summary
Dry powder inhalers (DPIs) are medical devices used to deliver medication directly into the lungs for the treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Unlike traditional inhalers that deliver medication in aerosol form, DPIs release a fine powder that the patient inhales into their lungs by taking a deep breath. The device typically consists of a reservoir containing the powdered medication and a mechanism to create a fine powder suitable for inhalation. DPIs are popular due to their ease of use and lack of propellants, making them environmentally friendly. Proper inhalation technique is important for effective medication delivery, as the patient's breath generates the airflow needed to disperse the powder. DPIs provide a convenient and efficient way to administer respiratory medications, improving patients' lung function and overall quality of life.
According to DIResearch's in-depth investigation and research, the global Dry Powder Inhalers market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Dry Powder Inhalers include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind, Novartis, Mylan, Schering/Merck, Teva, Vectura etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Dry Powder Inhalers. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Dry Powder Inhalers market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Dry Powder Inhalers market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Dry Powder Inhalers industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy. ? ?
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Dry Powder Inhalers Include:
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Novartis
Mylan
Schering/Merck
Teva
Vectura
Dry Powder Inhalers Product Segment Include:
Single Dose Inhaler
Multidose Inhaler
Dry Powder Inhalers Product Application Include:
Asthma
Chronic Obstructive Pulmonary Disease
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Dry Powder Inhalers Industry PESTEL Analysis
Chapter 3: Global Dry Powder Inhalers Industry Porter's Five Forces Analysis
Chapter 4: Global Dry Powder Inhalers Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Dry Powder Inhalers Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Dry Powder Inhalers Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Dry Powder Inhalers Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Dry Powder Inhalers Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Dry Powder Inhalers Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Dry Powder Inhalers Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Dry Powder Inhalers Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Dry Powder Inhalers Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Dry Powder Inhalers Market Overview 1.1 Product Definition and Statistical Scope 1.2 Dry Powder Inhalers Product by Type 1.2.1 Global Dry Powder Inhalers Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Single Dose Inhaler 1.2.3 Multidose Inhaler 1.3 Dry Powder Inhalers Product by Application 1.3.1 Global Dry Powder Inhalers Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Asthma 1.3.3 Chronic Obstructive Pulmonary Disease 1.3.4 Other 1.4 Global Dry Powder Inhalers Market Revenue and Sales Analysis 1.4.1 Global Dry Powder Inhalers Market Size Analysis (2019-2030) 1.4.2 Global Dry Powder Inhalers Market Sales Analysis (2019-2030) 1.4.3 Global Dry Powder Inhalers Market Sales Price Trend Analysis (2019-2030) 1.5 Dry Powder Inhalers Market Development Status and Trends 1.5.1 Dry Powder Inhalers Industry Development Status Analysis 1.5.2 Dry Powder Inhalers Industry Development Trends Analysis 2 Dry Powder Inhalers Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Dry Powder Inhalers Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Dry Powder Inhalers Market Analysis by Regions 4.1 Dry Powder Inhalers Overall Market: 2023 VS 2024 VS 2030 4.2 Global Dry Powder Inhalers Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Dry Powder Inhalers Revenue and Market Share by Region (2019-2024) 4.2.2 Global Dry Powder Inhalers Revenue Forecast by Region (2025-2030) 4.3 Global Dry Powder Inhalers Sales and Forecast Analysis (2019-2030) 4.3.1 Global Dry Powder Inhalers Sales and Market Share by Region (2019-2024) 4.3.2 Global Dry Powder Inhalers Sales Forecast by Region (2025-2030) 4.4 Global Dry Powder Inhalers Sales Price Trend Analysis (2019-2030) 5 Global Dry Powder Inhalers Market Size by Type and Application 5.1 Global Dry Powder Inhalers Market Size by Type 5.1.1 Global Dry Powder Inhalers Revenue and Forecast Analysis by Type (2019-2030) 5.1.2 Global Dry Powder Inhalers Sales and Forecast Analysis by Type (2019-2030) 5.2 Global Dry Powder Inhalers Market Size by Application 5.2.1 Global Dry Powder Inhalers Revenue and Forecast Analysis by Application (2019-2030) 5.2.2 Global Dry Powder Inhalers Sales and Forecast Analysis by Application (2019-2030) 6 North America 6.1 North America Dry Powder Inhalers Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Dry Powder Inhalers Market Size by Type 6.3.1 North America Dry Powder Inhalers Sales by Type (2019-2030) 6.3.2 North America Dry Powder Inhalers Revenue by Type (2019-2030) 6.4 North America Dry Powder Inhalers Market Size by Application 6.4.1 North America Dry Powder Inhalers Sales by Application (2019-2030) 6.4.2 North America Dry Powder Inhalers Revenue by Application (2019-2030) 6.5 North America Dry Powder Inhalers Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Dry Powder Inhalers Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Dry Powder Inhalers Market Size by Type 7.3.1 Europe Dry Powder Inhalers Sales by Type (2019-2030) 7.3.2 Europe Dry Powder Inhalers Revenue by Type (2019-2030) 7.4 Europe Dry Powder Inhalers Market Size by Application 7.4.1 Europe Dry Powder Inhalers Sales by Application (2019-2030) 7.4.2 ? Europe Dry Powder Inhalers Revenue by Application (2019-2030) 7.5 Europe Dry Powder Inhalers Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Dry Powder Inhalers Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Dry Powder Inhalers Market Size by Type 8.3.1 China Dry Powder Inhalers Sales by Type (2019-2030) 8.3.2 China Dry Powder Inhalers Revenue by Type (2019-2030) 8.4 China Dry Powder Inhalers Market Size by Application 8.4.1 China Dry Powder Inhalers Sales by Application (2019-2030) 8.4.2 China Dry Powder Inhalers Revenue by Application (2019-2030) 9 APAC (excl. China) 9.1 APAC (excl. China) Dry Powder Inhalers Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Dry Powder Inhalers Market Size by Type 9.3.1 APAC (excl. China) Dry Powder Inhalers Sales by Type (2019-2030) 9.3.2 APAC (excl. China) Dry Powder Inhalers Revenue by Type (2019-2030) 9.4 APAC (excl. China) Dry Powder Inhalers Market Size by Application 9.4.1 APAC (excl. China) Dry Powder Inhalers Sales by Application (2019-2030) 9.4.2 APAC (excl. China) Dry Powder Inhalers Revenue by Application (2019-2030) 9.5 APAC (excl. China) Dry Powder Inhalers Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Dry Powder Inhalers Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Dry Powder Inhalers Market Size by Type 10.3.1 Latin America Dry Powder Inhalers Sales by Type (2019-2030) 10.3.2 Latin America Dry Powder Inhalers Revenue by Type (2019-2030) 10.4 Latin America Dry Powder Inhalers Market Size by Application 10.4.1 Latin America Dry Powder Inhalers Sales by Application (2019-2030) 10.4.2 Latin America Dry Powder Inhalers Revenue by Application (2019-2030) 10.5 Latin America Dry Powder Inhalers Market Size by Country 10.5.1 Mexico 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Dry Powder Inhalers Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Dry Powder Inhalers Market Size by Type 11.3.1 Middle East & Africa Dry Powder Inhalers Sales by Type (2019-2030) 11.3.2 Middle East & Africa Dry Powder Inhalers Revenue by Type (2019-2030) 11.4 Middle East & Africa Dry Powder Inhalers Market Size by Application 11.4.1 Middle East & Africa Dry Powder Inhalers Sales by Application (2019-2030) 11.4.2 Middle East & Africa Dry Powder Inhalers Revenue by Application (2019-2030) 11.5 Middle East & Africa Dry Powder Inhalers Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Competition by Manufacturers 12.1 Global Dry Powder Inhalers Market Sales, Revenue and Price by Key Manufacturers (2020-2024) 12.1.1 Global Dry Powder Inhalers Market Sales by Key Manufacturers (2020-2024) 12.1.2 Global Dry Powder Inhalers Market Revenue by Key Manufacturers (2020-2024) 12.1.3 Global Dry Powder Inhalers Average Sales Price by Manufacturers (2020-2024) 12.2 Dry Powder Inhalers Competitive Landscape Analysis and Market Dynamic 12.2.1 Dry Powder Inhalers Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 GlaxoSmithKline 13.1.1 GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 GlaxoSmithKline Dry Powder Inhalers Product Portfolio 13.1.3 GlaxoSmithKline Dry Powder Inhalers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.2 AstraZeneca 13.2.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 AstraZeneca Dry Powder Inhalers Product Portfolio 13.2.3 AstraZeneca Dry Powder Inhalers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.3 Boehringer Ingelheim 13.3.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Boehringer Ingelheim Dry Powder Inhalers Product Portfolio 13.3.3 Boehringer Ingelheim Dry Powder Inhalers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.4 Chiesi 13.4.1 Chiesi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Chiesi Dry Powder Inhalers Product Portfolio 13.4.3 Chiesi Dry Powder Inhalers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.5 Cipla 13.5.1 Cipla Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Cipla Dry Powder Inhalers Product Portfolio 13.5.3 Cipla Dry Powder Inhalers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.6 3M 13.6.1 3M Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 3M Dry Powder Inhalers Product Portfolio 13.6.3 3M Dry Powder Inhalers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.7 Hovione 13.7.1 Hovione Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Hovione Dry Powder Inhalers Product Portfolio 13.7.3 Hovione Dry Powder Inhalers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.8 Mannkind 13.8.1 Mannkind Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Mannkind Dry Powder Inhalers Product Portfolio 13.8.3 Mannkind Dry Powder Inhalers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.9 Novartis 13.9.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Novartis Dry Powder Inhalers Product Portfolio 13.9.3 Novartis Dry Powder Inhalers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.10 Mylan 13.10.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Mylan Dry Powder Inhalers Product Portfolio 13.10.3 Mylan Dry Powder Inhalers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.11 Schering/Merck 13.11.1 Schering/Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 Schering/Merck Dry Powder Inhalers Product Portfolio 13.11.3 Schering/Merck Dry Powder Inhalers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.12 Teva 13.12.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 Teva Dry Powder Inhalers Product Portfolio 13.12.3 Teva Dry Powder Inhalers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.13 Vectura 13.13.1 Vectura Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.13.2 Vectura Dry Powder Inhalers Product Portfolio 13.13.3 Vectura Dry Powder Inhalers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Dry Powder Inhalers Industry Chain Analysis 14.2 Dry Powder Inhalers Industry Upstream Supply Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Dry Powder Inhalers Typical Downstream Customers 14.4 Dry Powder Inhalers Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Intrauterine Devices Market By Product Type (Hormonal Intrauterine Device and Copper Intrauterine Device), By Material (Plastic, Copper and Hormonal (Levonorgestrel)), By Age Group (15-24 years, 25-34 years, 35-44 years and Above 44 years), By End-user (Hospital, Gynecology Clinics, Community Health Care Centers and Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
- Arterial Thrombectomy Devices Market By Device Type (Aspiration Thrombectomy Devices, Mechanical Thrombectomy Devices, Rheolytic Thrombectomy Devices, Ultrasound-Assisted Thrombectomy Devices, Laser-Based Thrombectomy Devices, Others), By Application (Peripheral Arterial Disease (PAD), Coronary Artery Disease (CAD), Ischemic Stroke, Renal Artery Thrombosis, Acute limb Ischemia, Others), By End-user (Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Academic and Research Institutions), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
- Global Operating Room Infection Control Consumable Competitive Landscape Professional Research Report 2024
- Global Oral Fluid Drug Test System Competitive Landscape Professional Research Report 2024
- Global Orthopaedics Competitive Landscape Professional Research Report 2024
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support